Seeking Alpha

Cephalon wins lawsuit

(TEVA -0.9%) unit Cephalon wins its suit involving certain drug wholesalers who sued the company over its "pay for delay" agreements with generic competitors. Philadelphia District Court judge Mitchell Goldberg tossed the claims that Cephalon conspired with generics makers to delay cheaper versions of the sleep disorder drug Provigil saying that an overall conspiracy to improperly put off generic competition "cannot be established."

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs